Diabetes
Conference Coverage
Meet the rare diabetes diagnosis that thrills patients
When appropriate, endocrinologists should test for rare monogenetic form, experts say.
News
Fluoroquinolones can cause fatal hypoglycemia, FDA warns
Video
RISE: Insulin glargine, metformin offer no beta cell function benefit in youth
ORLANDO – Findings from pediatric portions of RISE, a T2DM medication study, are disappointing but lay strong foundation for future studies in...
Conference Coverage
CANVAS data: Canagliflozin generally well tolerated up to 6.5 years
The longest-term safety data to date show that canagliflozin is generally well tolerated for up to 6.5 years in patients with T2DM and high CV...
Conference Coverage
Uric acid tied to pediatric diabetic kidney disease
ORLANDO – A new indication for allopurinol?
Conference Coverage
Study spotlights risk factors for albuminuria in youth with T2DM
TORONTO – Both physical and mental health play an important role in kidney health.
Video
Chronic kidney disease is 40% more common in T2DM than T1DM
ORLANDO – Analysis of 1.5 million U.S. subjects reinforces importance of early warning via albumin testing.
Conference Coverage
CANVAS program analysis: Canagliflozin benefits patients with T2DM and poor kidney function
The cardioprotective benefits of canagliflozin in type 2 diabetes mellitus were similar across varying levels of kidney function in an analysis of...
From the Journals
Diabetes risk may rise with work hours
Women and men experience opposing effects.
Conference Coverage
High risk of low glucose? Hospital alerts promise a crucial heads-up
Incidents of severe hypoglycemia dropped by 41% after system was put into place to warn doctors.
Conference Coverage
Study questions canagliflozin amputation risk, but concerns remain
ORLANDO –